Sequential changes of serum KL-6 predict the progression of interstitial lung disease

Interstitial lung disease (ILD) is a slowly progressing fatal fibrotic lung disease with a widely variable clinical course and a poor prognosis. Clinicians and patients would benefit from a highly efficient and accurate predictor for ILD. The purpose of this study was to evaluate whether blood biomarkers can predict ILD progression.In this study, 85 patients diagnosed as having ILD at the Guangzhou Institute of Respiratory Health participated,...